SHANGHAI MODERN PHARMACEUTICAL CO LTD: Holding Subsidiary Obtains Drug Registration Certificate for Moxifloxacin Hydrochloride Eye Drops.
Sinopharm Modern Announces Its Subsidiary Obtains Drug Registration Certificate for Moxifloxacin Hydrochloride Eye Drops
Nov 01, 2023 15:50
CST Updated
15:48
Three pharmaceutical
Producer of External Skin Medications and Ophthalmic Drugs